Skip to content

Pulse oximetry during dental treatment in people with sickle cell disease

Pulse oximetry during dental treatment in people with Sickle Cell Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4k7rm6
Enrollment
Unknown
Registered
2015-08-28
Start date
2014-01-26
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anemia, sickle cell, oximetry, dental anxiety, fear, dental care.

Interventions

Single-arm, quasi- experimental study, with intra-group comparisons in three different moments ( M0, M1 and M2 ) : Taking into consideration dental treatment as intervention. M0 - Negative control gr
Behavioural
Other
E06.170.205

Sponsors

Universidade Federal do Rio de Janeiro -UFRJ
Lead Sponsor
Universidade Federal do Rio de Janeiro -UFRJ
Collaborator

Eligibility

Age
12 Years to 50 Years

Inclusion criteria

Inclusion criteria: Sixty six teens (from 12 years old) or adults (to 50 years old) with diagnosis and genotype for sickle cell disease established by blood test and medical clearance for dental treatment. Teens or adults with SCD who agree and sign the free and informed consent.Teens or adults with SCD and cognitive ability to answer the questionnaires. Teens or adults with SCD and adequate cognitive comportment whose laboratory and biochemical parameters enable the dental treatment.

Exclusion criteria

Exclusion criteria: Pregnancy, syndromes or any other condition that requires for care for people with special needs.Adolescents and adults with Sickle Cell Disease who received blood transfusions within 30 days; Teens or adults with Sickle Cell Disease and heart or lung disease. Teens or adults with Sickle Cell Disease and adenoidal or tonsillar obstruction. Teens or adults with Sickle Cell Disease and serology HIV positive. Teens or adults with Sickle Cell Disease and positive serology for viral hepatitis.Teens or adults with Sickle Cell Disease and hypertension.Teens or adults with Sickle Cell Disease undergoing hormone therapy. Lack of follow-up consultations by adolescents or adults with Sickle Cell Disease during the stages research.Teens or adults with Sickle Cell Disease in whom we could not use the pulse oximeter or reading the oximeter was inconsistent. Teens or adults with Sickle Cell Disease who have not responded the questionnaire on fear / anxiety during dental treatment. Teens or adults with Sickle Cell Disease who decline the survey, retirarando their terms of appointment or consent.

Design outcomes

Primary

MeasureTime frame
People with sickle cell disease will show level of oxygen saturation higher than 90%, before, during and after dental treatment.

Secondary

MeasureTime frame
People with sickle cell disease will be classified according to anxiety dental scale;

Countries

Brazil

Contacts

Public ContactMarcia Santos

Universidade Federal do Rio de Janeiro -UFRJ

dramarciaalves@gmail.com5521982152468

Outcome results

None listed

Source: REBEC (via WHO ICTRP)